[Regulation of bone metabolism and metabolic bone diseases]

[Primary hyperparathyroidism in childhood and adolescence].

Vutreshni bolesti·1982

[Case of Hashimoto's toxicosis with occult thyroid carcinoma].

Vutreshni bolesti·1981

[Biochemical and x-ray changes in thyroid osteopathy].

Vutreshni bolesti·1978

[Urinary hydroxyproline in hyperthyroidism].

Vutreshni bolesti·1977

[Idiopathic osteoporosis at an early age].

Vutreshni bolesti·1977

[Chronic recurrent pancreatitis with erosive gastritis in a patient with primary hyperparathyroidism].

Vutreshni bolesti·1976

[Comparative analysis of blood and urinary electrolytes in normotensive and hypertensive normal, overweight and obese subjects aged 50-54 in the Bulgarian army].

Vutreshni bolesti·2002

[Studies on restraint ulcers in rats in conditions of acute copper deficiency].

Vutreshni bolesti·2002

[Congestive heart failure--some current problems].

Vutreshni bolesti·2002

[Antioxidant parameters in metabolic syndrome -- a dynamic evaluation during oral glucose tolerance test].

Vutreshni bolesti·2002

[Interleukins and endocrine function].

Vutreshni bolesti·2002

[Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].

Vutreshni bolesti·2002

Recent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis.

Clinical and experimental hepatology·2026

Biological age acceleration and extrahepatic multimorbidity in U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cross-sectional study.

Clinical and experimental hepatology·2026

Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure: A Prospective Multicenter Study.

Journal of clinical and translational hepatology·2026

Short-Chain Fatty Acids: Microbial Metabolites Driving Gut-Eye Axis Signaling.

Comprehensive physiology·2026

AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.

Frontiers in medicine·2026

Integrative Multi-omics and Machine Learning Reveal the Therapeutic Mechanisms of Juanyu-Xiaozhi Formula in Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatic Fibrosis via the AP-1/PPARγ/SCD1 Axis.

Journal of clinical and translational hepatology·2026

Related Experiment Videos

[Regulation of bone metabolism and metabolic bone diseases]

Related Concept Videos

[Primary hyperparathyroidism in childhood and adolescence].

[Case of Hashimoto's toxicosis with occult thyroid carcinoma].

[Biochemical and x-ray changes in thyroid osteopathy].

[Urinary hydroxyproline in hyperthyroidism].

[Idiopathic osteoporosis at an early age].

[Chronic recurrent pancreatitis with erosive gastritis in a patient with primary hyperparathyroidism].

[Comparative analysis of blood and urinary electrolytes in normotensive and hypertensive normal, overweight and obese subjects aged 50-54 in the Bulgarian army].

[Studies on restraint ulcers in rats in conditions of acute copper deficiency].

[Congestive heart failure--some current problems].

[Antioxidant parameters in metabolic syndrome -- a dynamic evaluation during oral glucose tolerance test].

[Interleukins and endocrine function].

[Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].

Recent advances in the treatment of chronic liver diseases: focus on MASLD/MASH-related fibrosis.

Biological age acceleration and extrahepatic multimorbidity in U.S. adults with metabolic dysfunction-associated steatotic liver disease: a national cross-sectional study.

Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure: A Prospective Multicenter Study.

Short-Chain Fatty Acids: Microbial Metabolites Driving Gut-Eye Axis Signaling.

AI-driven diagnostic and prognostic models for metabolic dysfunction-associated steatotic liver disease: insights from clinical, imaging, and multi-omics studies-a scoping review.

Integrative Multi-omics and Machine Learning Reveal the Therapeutic Mechanisms of Juanyu-Xiaozhi Formula in Metabolic Dysfunction-associated Steatotic Liver Disease and Hepatic Fibrosis via the AP-1/PPARγ/SCD1 Axis.

Related Experiment Videos

[Regulation of bone metabolism and metabolic bone diseases]

Related Concept Videos

Related Articles